Company
Navigation

GPCR Applications of the CellKey System

Thursday, March 11, 2010     8:00am - 9:30am

View and download recording

Panelist Information:      
Dr. Matthew F Peters
Dr. Jonathan Ellery

Description:      
Label-free whole-cell assays provide an important tool in the arsenal of applications available for scientists involved in GPCR drug discovery. In this webinar, end user perspectives explore the unique applications of the impedance-based CellKey® System and will also discuss comparative studies involving other label-free technologies and more traditional GPCR assays.

Agenda:

Introduction
Debra Gallant, Molecular Devices

Comparison of Whole-cell Label-free Assays for GPCR Drug Discovery
Dr. Matthew F Peters, Prinicipal Scientist, AstraZeneca Pharmaceuticals

Application of the CellKey® System in Lead Optimization Studies; Experiences with in vitro and ex vivo cell sources
Dr. Jonathan Ellery, Principal Scientist, Takeda Cambridge Ltd